申请人:INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
公开号:US20040006131A1
公开(公告)日:2004-01-08
The invention concerns compounds of formula CH
3
—R
1
—(CH
2
)
2
—R
2
wherein: R
1
is selected among a tertiary alcohol; a 1,2-diol; a halohydrine; an epoxide; an alkene; an aldehyde or an &agr;-hydroxyaldehyde; and R
2
is selected among a methylenediphosphonate; a difluoromethylenediphosphonate; or a monofluoromethylenediphosphonate. The invention also concerns the uses of said compounds as selective inhibitors of T&ggr;9&dgr;2 lymphocytes, and their uses, in particular for therapeutic purposes.
本发明涉及式 CH
3
-R
1
-(CH
2
)
2
-R
2
其中R
1
选自叔醇;1,2-二醇;卤代烃;环氧化物;烯烃;醛或&agr;-羟基醛;以及 R
2
选自亚甲基二磷酸酯、二氟甲基二磷酸酯或单氟甲基二磷酸酯。本发明还涉及上述化合物作为T&ggr;9&dgr;2淋巴细胞选择性抑制剂的用途及其使用,特别是用于治疗目的。